STOCK TITAN

Peoples Bancorp Inc Financials

PEBO
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Peoples Bancorp Inc (PEBO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PEBO FY2025

Balance-sheet growth is continuing, but returns on assets and the cash cushion have moved the other way.

Between FY2023 and FY2025, assets grew by about $492M while operating cash flow fell by about $8.9M. That mismatch pushed return on assets from 1.24% to 1.11%, showing balance-sheet growth is no longer producing denser earnings and cash from each dollar of assets.

FY2025 liabilities rose by about $300M, but long-term debt fell to $204M; that says the company enlarged its funding base without leaning harder on term borrowing. The trade-off is a thinner cash buffer, with cash down to $189M from $427M in FY2023.

Physical reinvestment is light: capital spending was only $6M against $135M of operating cash flow in FY2025, so cash demands come more from managing the balance sheet than from maintaining hard assets. Goodwill stood at $363M, or about 30.1% of equity, meaning a noticeable slice of book value reflects prior acquisitions rather than tangible capital.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency Credit Quality Stability 48 / 100
Financial Health Score 48/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Peoples Bancorp Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
71
Growth
31
Capital
66
Efficiency
61
Credit Quality
13
Stability
45
Piotroski F-Score Partial
4/6

Peoples Bancorp Inc passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.26x

For every $1 of reported earnings, Peoples Bancorp Inc generates $1.26 in operating cash flow ($134.7M OCF vs $106.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk
0.8x

Peoples Bancorp Inc earns $0.8 in operating income for every $1 of interest expense ($134.8M vs $159.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$86.7M
YoY+2.3%
5Y CAGR+10.0%
10Y CAGR-2.2%

Peoples Bancorp Inc generated $86.7M in revenue in fiscal year 2025. This represents an increase of 2.3% from the prior year.

EBITDA
$149.3M
YoY-2.4%
5Y CAGR+16.9%
10Y CAGR+16.2%

Peoples Bancorp Inc's EBITDA was $149.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2.4% from the prior year.

Net Income
$106.8M
YoY-8.9%
5Y CAGR+25.2%
10Y CAGR+25.6%

Peoples Bancorp Inc reported $106.8M in net income in fiscal year 2025. This represents a decrease of 8.9% from the prior year.

EPS (Diluted)
$2.99
YoY-9.7%
5Y CAGR+11.6%
10Y CAGR+17.2%

Peoples Bancorp Inc earned $2.99 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 9.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$128.7M
YoY-5.6%
5Y CAGR+9.7%
10Y CAGR+12.8%

Peoples Bancorp Inc generated $128.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 5.6% from the prior year.

Cash & Debt
$189.0M
YoY-13.2%
5Y CAGR+4.4%
10Y CAGR+10.3%

Peoples Bancorp Inc held $189.0M in cash against $204.1M in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.63
YoY+2.5%
5Y CAGR+3.5%

Peoples Bancorp Inc paid $1.63 per share in dividends in fiscal year 2025. This represents an increase of 2.5% from the prior year.

Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
155.4%
YoY-20.8pp
5Y CAGR+76.4pp
10Y CAGR+141.8pp

Peoples Bancorp Inc's operating margin was 155.4% in fiscal year 2025, reflecting core business profitability. This is down 20.8 percentage points from the prior year.

Net Margin
123.1%
YoY-15.1pp
5Y CAGR+58.7pp
10Y CAGR+113.0pp

Peoples Bancorp Inc's net profit margin was 123.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 15.1 percentage points from the prior year.

Return on Equity
8.8%
YoY-1.7pp
5Y CAGR+2.8pp
10Y CAGR+6.2pp

Peoples Bancorp Inc's ROE was 8.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.7 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$838K
YoY-72.1%
5Y CAGR-50.9%

Peoples Bancorp Inc spent $838K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 72.1% from the prior year.

Capital Expenditures
$6.0M
YoY-11.7%
5Y CAGR+7.0%
10Y CAGR-4.4%

Peoples Bancorp Inc invested $6.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 11.7% from the prior year.

PEBO Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $22.4M+1.8% $22.0M+2.0% $21.5M+1.2% $21.3M-3.2% $22.0M+0.5% $21.9M+6.9% $20.4M-0.6% $20.6M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $39.8M+1.8% $39.1M+1.1% $38.7M-0.5% $38.9M-2.3% $39.8M+6.2% $37.5M+1.1% $37.1M+1.4% $36.6M
Operating Income $37.3M-1.7% $38.0M-0.1% $38.0M+38.4% $27.5M-12.5% $31.4M-10.0% $34.9M-14.7% $40.9M+14.0% $35.9M
Interest Expense $36.4M-7.8% $39.5M-4.7% $41.5M+6.8% $38.8M-1.2% $39.3M-7.0% $42.3M-5.5% $44.7M+1.2% $44.2M
Income Tax $8.3M+34.0% $6.2M-27.0% $8.5M+36.6% $6.2M-11.4% $7.0M-11.2% $7.9M-13.8% $9.2M+33.9% $6.9M
Net Income $29.0M-8.7% $31.8M+7.7% $29.5M+39.0% $21.2M-12.8% $24.3M-9.6% $26.9M-15.0% $31.7M+9.2% $29.0M
EPS (Diluted) $0.81 N/A $0.83+40.7% $0.59-13.2% $0.68 N/A $0.89+8.5% $0.82

PEBO Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $9.6B0.0% $9.6B+0.3% $9.6B+0.9% $9.5B+3.2% $9.2B-0.1% $9.3B+1.2% $9.1B-0.9% $9.2B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $190.4M+0.8% $189.0M-0.7% $190.2M+2.2% $186.1M-0.5% $187.0M-14.1% $217.7M-23.3% $283.7M+20.3% $235.9M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $363.2M0.0% $363.2M0.0% $363.2M0.0% $363.2M0.0% $363.2M0.0% $363.2M+0.2% $362.4M+0.1% $362.2M
Total Liabilities $8.4B-0.1% $8.4B0.0% $8.4B+0.6% $8.4B+3.4% $8.1B-0.4% $8.1B+1.6% $8.0B-1.6% $8.1B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $185.4M-9.2% $204.1M-10.2% $227.3M-2.2% $232.4M-1.9% $237.0M-0.5% $238.1M+0.5% $236.8M+1.1% $234.3M
Total Equity $1.2B+0.8% $1.2B+2.0% $1.2B+2.6% $1.2B+1.4% $1.1B+2.4% $1.1B-1.2% $1.1B+4.4% $1.1B
Retained Earnings $451.1M+3.3% $436.7M+3.7% $421.1M+3.6% $406.3M+2.0% $398.2M+2.6% $388.1M+3.4% $375.4M+4.9% $357.9M

PEBO Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $34.5M-2.3% $35.3M+145.0% $14.4M-71.6% $50.7M+47.9% $34.3M-14.2% $40.0M+17.2% $34.1M+6.2% $32.1M
Capital Expenditures $1.2M+961.4% $114K-93.3% $1.7M+15.5% $1.5M-46.6% $2.7M+1294.9% $197K-77.3% $866K-54.2% $1.9M
Free Cash Flow $33.3M-5.4% $35.2M+176.8% $12.7M-74.2% $49.2M+56.2% $31.5M-20.7% $39.8M+19.6% $33.2M+10.0% $30.2M
Investing Cash Flow -$10.8M+48.5% -$21.1M+70.9% -$72.4M+76.9% -$313.3M-1675.5% -$17.6M+91.9% -$217.7M-248.3% $146.8M+197.6% -$150.3M
Financing Cash Flow -$22.2M-43.1% -$15.5M-125.0% $62.2M-76.2% $261.7M+653.1% -$47.3M-142.4% $111.7M+184.0% -$133.0M-75.8% -$75.7M
Dividends Paid $14.6M+0.1% $14.6M-0.1% $14.7M+0.3% $14.6M+2.7% $14.2M+0.1% $14.2M+0.3% $14.2M+0.9% $14.0M
Share Buybacks $0-100.0% $383K $0-100.0% $455K $0 $0 $0 $0

PEBO Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin 167.0%-6.0pp 173.0%-3.6pp 176.5%+47.4pp 129.1%-13.8pp 142.8%-16.7pp 159.5%-40.5pp 200.0%+25.6pp 174.4%
Net Margin 129.7%-14.9pp 144.6%+7.7pp 136.9%+37.2pp 99.7%-11.0pp 110.8%-12.5pp 123.2%-31.8pp 155.0%+14.0pp 141.1%
Return on Equity 2.4%-0.2pp 2.6%+0.1pp 2.5%+0.6pp 1.8%-0.3pp 2.1%-0.3pp 2.4%-0.4pp 2.8%+0.1pp 2.7%
Return on Assets 0.3%-0.0pp 0.3%+0.0pp 0.3%+0.1pp 0.2%-0.0pp 0.3%-0.0pp 0.3%-0.1pp 0.4%+0.0pp 0.3%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.15-0.0 0.17-0.0 0.190.0 0.200.0 0.210.0 0.210.0 0.210.0 0.22
FCF Margin 148.9%-11.4pp 160.3%+101.2pp 59.1%-172.4pp 231.5%+88.0pp 143.5%-38.4pp 182.0%+19.3pp 162.6%+15.7pp 147.0%

Similar Companies

Frequently Asked Questions

Peoples Bancorp Inc (PEBO) reported $86.7M in total revenue for fiscal year 2025. This represents a 2.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Peoples Bancorp Inc (PEBO) revenue grew by 2.3% year-over-year, from $84.8M to $86.7M in fiscal year 2025.

Yes, Peoples Bancorp Inc (PEBO) reported a net income of $106.8M in fiscal year 2025, with a net profit margin of 123.1%.

Peoples Bancorp Inc (PEBO) reported diluted earnings per share of $2.99 for fiscal year 2025. This represents a -9.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Peoples Bancorp Inc (PEBO) had EBITDA of $149.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Peoples Bancorp Inc (PEBO) had $189.0M in cash and equivalents against $204.1M in long-term debt.

Peoples Bancorp Inc (PEBO) had an operating margin of 155.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Peoples Bancorp Inc (PEBO) had a net profit margin of 123.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Peoples Bancorp Inc (PEBO) paid $1.63 per share in dividends during fiscal year 2025.

Peoples Bancorp Inc (PEBO) has a return on equity of 8.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Peoples Bancorp Inc (PEBO) generated $128.7M in free cash flow during fiscal year 2025. This represents a -5.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Peoples Bancorp Inc (PEBO) generated $134.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Peoples Bancorp Inc (PEBO) had $9.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Peoples Bancorp Inc (PEBO) invested $6.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Peoples Bancorp Inc (PEBO) spent $838K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Peoples Bancorp Inc (PEBO) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Peoples Bancorp Inc (PEBO) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Peoples Bancorp Inc (PEBO) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Peoples Bancorp Inc (PEBO) has an earnings quality ratio of 1.26x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Peoples Bancorp Inc (PEBO) has an interest coverage ratio of 0.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Peoples Bancorp Inc (PEBO) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top